Quick answer: ASD requires persistent deficits in social communication across all three domains plus restricted/repetitive behaviors, with onset in early development — severity levels 1–3 grade support needs. Schizophrenia requires ≥2 of 5 psychotic symptom domains (≥1 from delusions/hallucinations/disorganized speech) for ≥6 months with functional decline — coded F20.x.
Why These Two Diagnoses Belong in One Guide
ASD and schizophrenia sit in different DSM-5-TR chapters but share two things that make them the most-searched and most-consequential diagnoses to get right: both are defined by fixed, countable criteria (unlike the dimensional mood/anxiety disorders), and both carry lifetime stakes — an ASD determination drives school services, disability support, and developmental intervention, while a schizophrenia diagnosis drives antipsychotic treatment, monitoring, and disability documentation.
They also share a differential-diagnosis boundary: late-adolescent social withdrawal, odd speech, and restricted interests can present in either — and the distinction (premorbid developmental history vs. psychotic decline) is exactly where misdiagnosis happens. This guide serves psychiatrists, psychologists, developmental pediatricians, and primary care clinicians making referrals, with the documentation stakes explicit for each.
Part 1 — Autism Spectrum Disorder (ASD)
Criteria A & B — The Two Pillars
| Criterion | Requirement | Sub-criteria |
|---|---|---|
| A — Social communication | Persistent deficits in social communication and social interaction across contexts | ALL THREE required: (1) social-emotional reciprocity; (2) nonverbal communicative behaviors; (3) developing/maintaining/understanding relationships |
| B — Restricted/repetitive | Restricted, repetitive patterns of behavior, interests, or activities | ≥2 of 4: (1) stereotyped/repetitive motor movements or speech; (2) insistence on sameness/inflexible routines; (3) highly restricted fixated interests of abnormal intensity; (4) hyper- or hyporeactivity to sensory input |
| C — Onset | Symptoms present in the early developmental period | May not fully manifest until social demands exceed capacities |
| D — Impairment | Clinically significant impairment in social, occupational, or other important areas | Current functioning, not potential |
| E — Exclusions | Not better explained by intellectual disability or global developmental delay | Social communication deficits must exceed what general developmental level predicts |
Severity Levels — What Levels 1/2/3 Actually Mean
| Level | Support needed | Social communication | Restricted/repetitive behaviors |
|---|---|---|---|
| Level 1 | Requiring support | Noticeable deficits without supports; may appear awkward | Inflexibility causes significant interference in one or more contexts |
| Level 2 | Requiring substantial support | Marked deficits apparent even with supports; limited initiation of social interaction | Inflexibility or restricted behaviors apparent to casual observers; interfere with functioning in multiple contexts |
| Level 3 | Requiring very substantial support | Severe deficits in verbal/nonverbal communication; very limited initiation; minimal response to social approaches | Inflexibility/behaviors markedly interfere with functioning in all spheres; great distress when changed |
ASD Specifiers
| Specifier | Options |
|---|---|
| Intellectual impairment | With or without accompanying intellectual impairment |
| Language impairment | With or without accompanying language impairment |
| Associated conditions | Associated with another neurodevelopmental, mental, or behavioral disorder (specify) |
| Catatonia | With catatonia |
Diagnostic Instruments (Not Screeners)
| Instrument | Purpose | Who administers |
|---|---|---|
| ADOS-2 | Gold-standard observational assessment of social communication + restricted behaviors | Trained clinician |
| ADI-R | Parent/caregiver interview on developmental history | Trained clinician |
| M-CHAT-R/F | Toddler screening (16–30 months) | Parent completes; positive → referral |
ASD Differential — What Else Looks Like Autism
| Differential | Distinguishing features |
|---|---|
| Intellectual disability | Global cognitive deficits; social communication deficits do not exceed what the developmental level predicts — if they do, ASD is comorbid and both are coded |
| Social (pragmatic) communication disorder | Social communication deficits without restricted/repetitive behaviors (criterion B) — if criterion B is present, it's ASD |
| Schizophrenia | Psychotic decline with delusions/hallucinations and loss of previously acquired skills; ASD shows lifelong, stable-at-core patterns with early onset |
| ADHD | Distractibility and social difficulties from inattention, not from reciprocity deficits; frequently comorbid — both can be coded |
| Reactive attachment / trauma | Social withdrawal follows neglect or disruption; improves with stable caregiving; no restricted/repetitive criterion-B behaviors |
Severity levels are functional, not fixed traits. Level 1/2/3 describes current support needs — a child can move levels across development as demands change (a level-1 presentation in elementary school can become level-2 in middle school's unstructured social environment). Re-assess and update the specifier at each major transition; the level is part of the documented diagnosis, not a permanent label.
Sample documentation:
Patient meets DSM-5-TR criteria for Autism Spectrum Disorder, Level 2 requiring substantial support, without accompanying intellectual impairment (F84.0): deficits in all three social communication domains (limited reciprocity, flat prosody and reduced eye contact, difficulty maintaining peer relationships) plus 3 of 4 criterion-B behaviors (hand-flapping, insistence on sameness with distress at routine changes, circumscribed interest in train schedules, auditory hyperreactivity). Onset in early development per caregiver report and school records. ADOS-2 administered — scores consistent with ASD. Not better explained by intellectual disability (FSIQ 95).
Part 2 — Schizophrenia
The 5 Psychotic Symptom Domains
| Domain | Examples | Required? |
|---|---|---|
| Delusions | Fixed false beliefs despite contradictory evidence | At least one of these three is required |
| Hallucinations | Perception without external stimulus (auditory most common) | |
| Disorganized speech | Frequent derailment/incoherence, tangentiality, word salad | |
| Grossly disorganized or catatonic behavior | Daily-life dysfunction, unpredictable agitation, catatonia | Optional (only 2 domains needed if these are present) |
| Negative symptoms | Diminished emotional expression, avolition, alogia, anhedonia, asociality | Optional |
Duration and Course Criteria
| Criterion | Requirement |
|---|---|
| Symptom count | ≥2 of 5 domains for a significant portion of time during a 1-month period (or less if successfully treated) |
| Mandatory domain | At least one of: delusions, hallucinations, or disorganized speech |
| Total duration | Continuous signs of the disturbance persist for ≥6 months; the 1-month active phase must be included within it |
| Prodromal/residual | The 6-month period includes prodromal or residual symptoms (may be negative symptoms or attenuated psychotic symptoms) |
| Functional decline | Level of functioning in work/school/relationships is markedly below premorbid level (or failure to achieve expected level in youth) |
| Exclusions | Not attributable to substances or another medical condition; not better explained by schizoaffective, depressive, or bipolar disorder with psychotic features |
Schizophrenia Spectrum — Differential Table
| Disorder | DSM-5-TR code | Duration | Distinguishing feature |
|---|---|---|---|
| Schizophrenia | F20.x | ≥6 months (≥1 month active) | Functional decline; negative symptoms |
| Schizophreniform | F20.81 | 1–6 months | Same symptoms, shorter duration, recovery expected |
| Brief psychotic | F23 | 1 day–1 month | Full return to premorbid functioning |
| Schizoaffective | F25.x | ≥6 months | Mood episode + ≥2 weeks psychosis without mood episode |
| Delusional | F22 | ≥1 month | Delusions only; functioning preserved outside delusion |
| Substance/medication-induced | F1x.5/F05 | Variable | Temporally related to substance or GMC |
| Psychotic disorder due to GMC | F06.2 | Variable | Attributable to another medical condition |
ICD-10-CM F20.x Code Map
| Code | Diagnosis |
|---|---|
| F20.0 | Paranoid schizophrenia |
| F20.1 | Disorganized schizophrenia |
| F20.2 | Catatonic schizophrenia |
| F20.3 | Undifferentiated schizophrenia |
| F20.5 | Residual schizophrenia |
| F20.81 | Schizophreniform disorder |
| F20.89 | Other schizophrenia spectrum disorders |
| F20.9 | Schizophrenia, unspecified |
The Rule-Out Order — Before Coding Any Psychotic Disorder
Work the differential in this order, because each step excludes the next:
- Substances — stimulant intoxication, cannabis-induced psychosis, corticosteroids (urine drug screen + medication review)
- Medical conditions — thyroid disease, autoimmune encephalitis, temporal lobe epilepsy, delirium (TSH, CBC, metabolic panel, neuro exam)
- Mood disorders with psychotic features — psychosis only during mood episodes = mood disorder with psychotic features, not schizophrenia
- Developmental context — ASD with atypical presentation is not psychosis; obsessions with absent insight are not delusions
First-episode psychosis pathway: for a first presentation, document the timeline carefully — prodromal period (social withdrawal, avolition, odd beliefs), active-phase onset, and functional decline. Duration determines the code: 1 day–1 month → brief psychotic disorder (F23); 1–6 months → schizophreniform (F20.81); ≥6 months → schizophrenia (F20.x). Schizophreniform is the provisional diagnosis while the course clarifies.
Clinical high risk (CHR/UHR) screening: the CAARMS (Comprehensive Assessment of At-Risk Mental States) identifies attenuated psychotic symptoms in help-seeking adolescents and young adults before full criteria are met. CHR states are documented as "other specified schizophrenia spectrum disorder" (F28/F29) — not schizophrenia — and justify monitoring rather than antipsychotic initiation in most guidelines.
Sample documentation:
Patient meets DSM-5-TR criteria for Schizophrenia (F20.9): auditory hallucinations (commenting voices) and persecutory delusions present for 5 months, with 8 months of prodromal social withdrawal and avolition. Functioning declined from full-time employment. Urine drug screen negative; TSH, CBC, metabolic panel unremarkable; no mood episodes meeting criteria. Olanzapine initiated; metabolic monitoring scheduled.
Cross-Diagnosis Comparison
| Feature | ASD | Schizophrenia |
|---|---|---|
| Chapter | Neurodevelopmental | Schizophrenia Spectrum & Other Psychotic |
| Onset | Early developmental period | Typically late adolescence/early adulthood |
| Core deficit | Social communication + restricted behaviors | Psychotic symptoms (delusions/hallucinations/disorganization) |
| Insight | Preserved (may be odd but not psychotic) | Impaired during active phase |
| Course | Lifelong neurodevelopmental | Episodic with possible residual phase |
| ICD-10-CM | F84.0 | F20.x |
| Severity measure | Levels 1–3 (support needs) | Specifiers: severity, course, catatonia |
Screening and Assessment in the EHR
Neither ASD nor schizophrenia has a PHQ-9-style brief screen that establishes the diagnosis — the workup runs on structured instruments and longitudinal observation:
| Diagnosis | Instruments | Workflow |
|---|---|---|
| ASD | ADOS-2 + ADI-R (diagnostic), M-CHAT-R/F (toddler screen) | Positive M-CHAT → referral for ADOS-2/ADI-R; caregiver developmental history is criterion evidence |
| Schizophrenia (CHR) | CAARMS | Attenuated symptoms → F28/F29 monitoring, not antipsychotics |
| Schizophrenia (established) | PANSS / BPRS (severity tracking) | Serial scores document treatment response |
| Comorbidity screens | PHQ-9, GAD-7, MMSE | Depression and anxiety co-occur with both; cognition in psychosis |
In Neuraline, the AI Screening module carries the comorbidity layer — PHQ-9, GAD-7, Y-BOCS, BDI, HAM-D, and MMSE pre-seeded with auto-scoring and severity bands — while encounter templates hold the structured criteria checklists for ASD (criteria A/B with all sub-items) and schizophrenia (5 domains + duration). 3-click AI Charting drafts the note with instrument scores, criteria checklists, and the coded diagnosis embedded — draft, review, sign. For ASD specifically, caregiver-reported developmental history attaches to the encounter as documentation supporting the early-onset criterion.
Frequently Asked Questions
What are ASD severity levels 1, 2, and 3?
They grade current support needs, not ability: Level 1 = requiring support (noticeable deficits without supports); Level 2 = requiring substantial support (marked deficits apparent even with supports); Level 3 = requiring very substantial support (severe deficits, minimal initiation or response to social approaches). Levels are reassessed as development and environment change.
Can someone have both ASD and schizophrenia?
Yes — DSM-5-TR explicitly allows comorbid ASD and schizophrenia when both criteria sets are independently met. Historically the diagnoses were considered mutually exclusive (DSM-III/IV "pervasive developmental disorder" exclusion); DSM-5 removed that exclusion. Document both with separate codes (F84.0 + F20.x) when both are established.
How long must symptoms last for a schizophrenia diagnosis?
≥6 months of continuous disturbance, which must include at least 1 month of active-phase symptoms (≥2 of the 5 domains, at least one being delusions, hallucinations, or disorganized speech). Prodromal and residual periods count toward the 6 months. Under 6 months → schizophreniform; under 1 month → brief psychotic disorder.
What code do I use for autism with intellectual impairment?
The base code is still F84.0 — intellectual impairment is a specifier ("with accompanying intellectual impairment"), documented in the note. If intellectual disability is also independently diagnosed, code both: F84.0 + F70–F79 as applicable. The severity level (1/2/3) is likewise documented, not coded.
This guide summarizes DSM-5-TR criteria for clinical reference. Diagnosis requires a qualified clinician's evaluation — screeners and checklists support but never replace the diagnostic interview.
Neuraline's AI Screening module automates instrument scoring and severity tracking across your practice. Explore screening or book a demo.
About Neuraline
Neuraline (neura-line.com) is an AI-powered Electronic Health Record (EHR), practice management, and medical billing platform for independent healthcare practices.
